Compugen Ltd. , a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Compugen stock last closed at $1.90, down 6.4% from the previous day, and has increased 196.88% in one year. It has overperformed other stocks in the Biotechnology industry by 2.23 percentage points. Compugen stock is currently +258.49% from its 52-week low of $0.53, and -37.29% from its 52-week high of $3.03.
There are currently 88.42M CGEN shares outstanding. The market capitalization of CGEN is $167.99M. In the past 24 hours, 371,856 CGEN shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy CGEN shares.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountNow that you've chosen your brokerage, you need to fill out some personal info so you are able to invest in CGEN today.
Now that you have opened your account on app for stock market, you can securely and quickly fund your account:
Check out the tutorial below for more details transferring money into your brokerage account.
After you have identified the best place to buy Compugen stock, it's important to evaluate their stock prior to buying, so you can comprehend the risk and opportunity.
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CGEN's true value.
Using relative valuations methods:
You can access more valuation analysis on CGEN's stock here.
Out of 2 sell side analysts who give recommendations on CGEN, the consensus analyst rating on CGEN is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Compugen stock forecast page.
Last year, CGEN revenue was $33.46M. Over the past five year, CGEN's revenue has increased by 13.45% per year. This was slower than the Biotechnology industry average of 29.02%.
Dig into CGEN's earnings and revenue performance here.
In the last year, executives and large shareholders at CGEN have not bought or sold any shares.
Get more info about who owns CGEN stock here.
No, Compugen doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary types of orders:
Click the Open button and your broker will execute your order.
If you require more info about investing in stocks on eToro, click the how to video below:
Now that you own some shares in CGEN, you'll want to stay up-to-date on your shares.
Create a watchlist to keep track of your CGEN stock.
To reiterate, here are the 6 steps to buy stock in Compugen:
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Compugen, create a watchlist today.